Combination Therapy: Are Two Drugs More Effective to Combat CLL? Anthony Mato, MD, MSCE, William Wierda, MD, PhD, Andrew Schorr
BTK Inhibitor Update From ASH 2017: What Are the Real-World Results? Anthony Mato, MD, MSCE, Jennifer R. Brown, MD, PhD, Andrew Schorr